| Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation AS Papazoglou, A Kartas, DV Moysidis, C Tsagkaris, SP Papadakos, ... Cardiovascular Diabetology 21 (1), 39, 2022 | 36 | 2022 |
| Prognostic significance of diabetes mellitus in patients with atrial fibrillation AS Papazoglou, A Kartas, A Samaras, I Vouloagkas, E Vrana, ... Cardiovascular diabetology 20, 1-11, 2021 | 35 | 2021 |
| Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease E Karagiannidis, DV Moysidis, AS Papazoglou, E Panteris, O Deda, ... Cardiovascular Diabetology 21 (1), 70, 2022 | 33 | 2022 |
| Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial A Tzikas, A Samaras, A Kartas, D Vasdeki, G Fotos, G Dividis, E Paschou, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (FI1), f63-f71, 2021 | 33 | 2021 |
| Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral Anticoagulation adherence versus usual care in patients with nonvalvular atrial … A Samaras, A Kartas, D Vasdeki, G Dividis, E Forozidou, G Fotos, E Kotsi, ... Hell J Cardiol 61, 453-454, 2020 | 30 | 2020 |
| Non-vitamin K oral anticoagulants in adults with congenital heart disease: a systematic review N Stalikas, I Doundoulakis, E Karagiannidis, E Bouras, A Kartas, ... Journal of clinical medicine 9 (6), 1794, 2020 | 28 | 2020 |
| Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: a systematic review N Stalikas, I Doundoulakis, E Karagiannidis, A Kartas, M Gavriilaki, ... European Journal of Internal Medicine 99, 38-44, 2022 | 25 | 2022 |
| Association of GRACE risk score with coronary artery disease complexity in patients with acute coronary syndrome G Sofidis, N Otountzidis, N Stalikas, E Karagiannidis, AS Papazoglou, ... Journal of Clinical Medicine 10 (10), 2210, 2021 | 19 | 2021 |
| Correlation of the severity of coronary artery disease with patients' metabolic profile-rationale, design and baseline patient characteristics of the CorLipid trial E Karagiannidis, G Sofidis, AS Papazoglou, O Deda, E Panteris, ... BMC Cardiovascular Disorders 21 (1), 79, 2021 | 18 | 2021 |
| A novel prognostic tool to predict mortality in patients with atrial fibrillation: the BASIC-AF risk score A Samaras, A Kartas, E Akrivos, G Fotos, G Dividis, D Vasdeki, E Vrana, ... Hellenic Journal of Cardiology 62 (5), 339-348, 2021 | 16 | 2021 |
| Serum ceramides as prognostic biomarkers of large thrombus burden in patients with STEMI: a micro-computed tomography study E Karagiannidis, AS Papazoglou, N Stalikas, O Deda, E Panteris, ... Journal of personalized medicine 11 (2), 89, 2021 | 16 | 2021 |
| Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial A Tzikas, A Samaras, A Kartas, D Vasdeki, G Fotos, G Dividis, E Paschou, ... European Heart Journal 41 (Supplement_2), ehaa946. 0641, 2020 | 16 | 2020 |
| Flaws in anticoagulation strategies in patients with atrial fibrillation at hospital discharge A Kartas, A Samaras, D Vasdeki, G Dividis, G Fotos, E Paschou, ... Journal of cardiovascular pharmacology and therapeutics 24 (3), 225-232, 2019 | 16 | 2019 |
| CERT2 ceramide-and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis AS Papazoglou, N Stalikas, DV Moysidis, N Otountzidis, A Kartas, ... Journal of Clinical Lipidology 16 (3), 272-276, 2022 | 15 | 2022 |
| The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations A Bekiaridou, A Kartas, DV Moysidis, AS Papazoglou, A Baroutidou, ... Reviews in Endocrine and Metabolic Disorders 23 (3), 621-630, 2022 | 14 | 2022 |
| Micro-CT-based quantification of extracted thrombus burden characteristics and association with angiographic outcomes in patients with ST-elevation myocardial infarction: the … E Karagiannidis, AS Papazoglou, G Sofidis, E Chatzinikolaou, ... Frontiers in cardiovascular medicine 8, 646064, 2021 | 14 | 2021 |
| Risk for recurrent cardiovascular events and expected risk reduction with optimal treatment 1 year after an acute coronary syndrome S Zafeiropoulos, I Farmakis, A Kartas, A Arvanitaki, A Pagiantza, ... The American Journal of Cardiology 133, 7-14, 2020 | 14 | 2020 |
| Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design A Boulmpou, A Kartas, I Farmakis, S Zafeiropoulos, V Nevras, ... Hellenic Journal of Cardiology 60 (4), 249-253, 2019 | 14 | 2019 |
| Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial S Zafeiropoulos, I Farmakis, A Kartas, A Arvanitaki, A Pagiantza, ... Atherosclerosis 323, 37-43, 2021 | 13 | 2021 |
| Renal function and mortality in patients with atrial fibrillation E Liampas, A Kartas, A Samaras, AS Papazoglou, DV Moysidis, E Vrana, ... Journal of Cardiovascular Medicine 23 (7), 430-438, 2022 | 11 | 2022 |
George GiannakoulasAristotle University of ThessalonikiVerified email at auth.gr
